EN / 中文
您的位置： 首页 > 2023年4月 第54卷 第4期 > 文字全文
2023年7月 第38卷 第7期11
目录

纳米药物重编程肿瘤相关巨噬细胞增强抗癌效果

Recent progress of nanoparticle reprogramming of tumor-associated macrophages（TAMs）to enhance anti-tumor activity

来源期刊： 广州医药 | 1-13 发布时间：2023-05-18 收稿时间：2025/11/13 18:34:56 阅读量：8
作者：
陈明娃,
王俊侠,
关键词：
纳米药物肿瘤相关巨噬细胞（TAMs）肿瘤治疗
nanomedicinetumor associated macrophages（TAMs）tumor therapy
DOI：
10.3969/j.issn.1000-8535.2023.04.001
收稿时间：
2023-02-01 
修订日期：
 
接收日期：
 
引用总数：
0  
肿瘤相关巨噬细胞（TAMs）是肿瘤微环境中最丰富的免疫细胞之一,M2-TAMs在肿瘤发生、发展、转移和治疗过程中发挥重要作用,被认为是肿瘤治疗中的重要靶点。已有的研究表明,通过将促肿瘤的M2-TAMs重编程为促炎的M1-TAMs可实现抑制肿瘤生长和转移。本综述在介绍TAMs与肿瘤治疗相关背景的基础上,重点关注纳米药物重编程TAMs增强抗肿瘤的研究进展。本文将从TAMs靶向递送各种活性物质进行重编程TAMs和纳米药物介导的异常肿瘤微环境调节的间接重编程TAMs两种方式,综述近年来基于纳米药物递送系统的调控策略及典型例子。
Tumor associated macrophages（TAMs）is one of the most abundant immune cells in the tumor microenvironment．M2-TAMs play an important role in tumor genesis,progression,metastasis and treatment,and is additionally a very important target in tumor therapy．Previous studies have shown that inhibition of tumor growth and metastasis can be achieved by reprogramming M2-TAMs to M1-TAMs．On the basis,this review focuses on the analysis progress of nano-drug reprogramming TAMs to boost anti-tumor．In this paper,we reviewed two methods of reprogramming TAMs for targeted delivery of various active substances and indirect reprogramming TAMs for abnormal tumor microenvironment regulation mediated by nanomedicine．The regulatory strategies and typical samples of nanomedicine delivery systems in recent years were summarized.
1、 ZHANG W,SHI Y,LI H,et al.In situ injectable nano-complexed hydrogel based on chitosan/dextran for combining tumor therapy via hypoxia alleviation and TAMs polarity regulation[J].Carbohydrate Polymers,2022(288):119418. ZHANG W,SHI Y,LI H,et al.In situ injectable nano-complexed hydrogel based on chitosan/dextran for combining tumor therapy via hypoxia alleviation and TAMs polarity regulation[J].Carbohydrate Polymers,2022(288):119418.
2、 CHEN Q,CHEN J,YANG Z,et al.Nanoparticle-enhanced radiotherapy to trigger robust cancer immunotherapy[J].Adv Mater,2019,31(10):e1802228. CHEN Q,CHEN J,YANG Z,et al.Nanoparticle-enhanced radiotherapy to trigger robust cancer immunotherapy[J].Adv Mater,2019,31(10):e1802228.
3、 BHANDARI V,HOEY C,LIU L Y,et al.Molecular landmarks of tumor hypoxia across cancer types[J].Nature Genetics,2019,51(2):308-318. BHANDARI V,HOEY C,LIU L Y,et al.Molecular landmarks of tumor hypoxia across cancer types[J].Nature Genetics,2019,51(2):308-318.
4、 LIU L,HE H,LIANG R,et al.ROS-Inducing micelles sensitize tumor-associated macrophages to tlr3 stimulation for potent immunotherapy[J].Biomacromolecules,2018,19(6):2146-2155. LIU L,HE H,LIANG R,et al.ROS-Inducing micelles sensitize tumor-associated macrophages to tlr3 stimulation for potent immunotherapy[J].Biomacromolecules,2018,19(6):2146-2155.
5、 SHI C,LIU T,GUO Z,et al.Reprogramming tumor-associated macrophages by nanoparticle-based reactive oxygen species photogeneration[J].Nano Lett,2018,18(11):7330-7342. SHI C,LIU T,GUO Z,et al.Reprogramming tumor-associated macrophages by nanoparticle-based reactive oxygen species photogeneration[J].Nano Lett,2018,18(11):7330-7342.
6、 ZANGANEH S,HUTTER G,SPITLER R,et al.Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues[J].Nat Nanotechnol,2016,11(11):986-994. ZANGANEH S,HUTTER G,SPITLER R,et al.Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues[J].Nat Nanotechnol,2016,11(11):986-994.
7、 COVARRUBIAS A,BYLES V,HORNG T.ROS sets the stage for macrophage differentiation[J].Cell Res,2013,23(8):984-985. COVARRUBIAS A,BYLES V,HORNG T.ROS sets the stage for macrophage differentiation[J].Cell Res,2013,23(8):984-985.
8、 ZHANG Y,CHOKSI S,CHEN K,et al.ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages[J].Cell research,2013,23(7):898-914. ZHANG Y,CHOKSI S,CHEN K,et al.ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages[J].Cell research,2013,23(7):898-914.
9、 WANG H,TANG Y,FANG Y,et al.Reprogramming tumor immune microenvironment(time)and metabolism via biomimetic targeting codelivery of shikonin/JQ1[J].Nano Lett,2019,19(5):2935-2944. WANG H,TANG Y,FANG Y,et al.Reprogramming tumor immune microenvironment(time)and metabolism via biomimetic targeting codelivery of shikonin/JQ1[J].Nano Lett,2019,19(5):2935-2944.
10、 KELLY B,O'NEILL L A.Metabolic reprogramming in macrophages and dendritic cells in innate immunity[J].Cell research,2015,25(7):771-784. KELLY B,O'NEILL L A.Metabolic reprogramming in macrophages and dendritic cells in innate immunity[J].Cell research,2015,25(7):771-784.
11、 ESCRIBESE M M,CASAS M,CORBí A L.Influence of low oxygen tensions on macrophage polarization[J].Immunobiology,2012,217(12):1233-1240. ESCRIBESE M M,CASAS M,CORBí A L.Influence of low oxygen tensions on macrophage polarization[J].Immunobiology,2012,217(12):1233-1240.
12、 QIAN H,ZHOU T,FU Y,et al.Self-assembled tetrahedral framework nucleic acid mediates tumor-associated macrophage reprogramming and restores antitumor immunity[J].Molecular therapy Nucleic acids,2022(27):763-773. QIAN H,ZHOU T,FU Y,et al.Self-assembled tetrahedral framework nucleic acid mediates tumor-associated macrophage reprogramming and restores antitumor immunity[J].Molecular therapy Nucleic acids,2022(27):763-773.
13、 PARAYATH N N,PARIKH A,AMIJI M M.Repolarization of tumor-associated macrophages in a genetically engineered nonsmall cell lung cancer model by intraperitoneal administration of hyaluronic acid-based nanoparticles encapsulating microrna-125b[J].Nano Lett,2018,18(6):3571-3579. PARAYATH N N,PARIKH A,AMIJI M M.Repolarization of tumor-associated macrophages in a genetically engineered nonsmall cell lung cancer model by intraperitoneal administration of hyaluronic acid-based nanoparticles encapsulating microrna-125b[J].Nano Lett,2018,18(6):3571-3579.
14、 LIU L,YI H,HE H,et al.Tumor associated macrophage-targeted microRNA delivery with dual-responsive polypeptide nanovectors for anti-cancer therapy[J].Biomaterials,2017(134):166-179. LIU L,YI H,HE H,et al.Tumor associated macrophage-targeted microRNA delivery with dual-responsive polypeptide nanovectors for anti-cancer therapy[J].Biomaterials,2017(134):166-179.
15、 YIN W,YU X,KANG X,et al.Remodeling tumor-associated macrophages and neovascularization overcomes eGFR(T790M)-associated drug resistance by PD-L1 nanobody-mediated codelivery[J].Small,2018,14(47):e1802372. YIN W,YU X,KANG X,et al.Remodeling tumor-associated macrophages and neovascularization overcomes eGFR(T790M)-associated drug resistance by PD-L1 nanobody-mediated codelivery[J].Small,2018,14(47):e1802372.
16、 JIN H,HE Y,ZHAO P,et al.Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery[J].Theranostics,2019,9(1):265-278. JIN H,HE Y,ZHAO P,et al.Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery[J].Theranostics,2019,9(1):265-278.
17、 CHEN M,MIAO Y, QIAN K,et al.Detachable liposomes combined immunochemotherapy for enhanced triple-negative breast cancer treatment through reprogramming of tumor-associated macrophages[J].Nano Lett,2021,21(14):6031-6041. CHEN M,MIAO Y, QIAN K,et al.Detachable liposomes combined immunochemotherapy for enhanced triple-negative breast cancer treatment through reprogramming of tumor-associated macrophages[J].Nano Lett,2021,21(14):6031-6041.
18、 LIN M,YANG Z,YANG Y,et al.CRISPR-based in situ engineering tumor cells to reprogram macrophages for effective cancer immunotherapy[J].Nano Today,2022(42):101359. LIN M,YANG Z,YANG Y,et al.CRISPR-based in situ engineering tumor cells to reprogram macrophages for effective cancer immunotherapy[J].Nano Today,2022(42):101359.
19、 SUN J H,LIANG X,CAI M,et al.Protein-crowned micelles for targeted and synergistic tumor-associated macrophage reprogramming to enhance cancer treatment[J].Nano Lett,2022,22(11):4410-4420. SUN J H,LIANG X,CAI M,et al.Protein-crowned micelles for targeted and synergistic tumor-associated macrophage reprogramming to enhance cancer treatment[J].Nano Lett,2022,22(11):4410-4420.
20、 LI M,LI M,YANG Y,et al.Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy[J].J Control Release,2020(321):23-35. LI M,LI M,YANG Y,et al.Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy[J].J Control Release,2020(321):23-35.
21、 LI K,LU L,XUE C,et al.Polarization of tumor-associated macrophage phenotype via porous hollow iron nanoparticles for tumor immunotherapy in vivo[J].Nanoscale,2020,12(1):130-144. LI K,LU L,XUE C,et al.Polarization of tumor-associated macrophage phenotype via porous hollow iron nanoparticles for tumor immunotherapy in vivo[J].Nanoscale,2020,12(1):130-144.
22、 DE HENAU O,RAUSCH M,WINKLER D,et al.Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells[J].Nature,2016,539(7629):443-447. DE HENAU O,RAUSCH M,WINKLER D,et al.Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells[J].Nature,2016,539(7629):443-447.
23、 KANEDA M M,MESSER K S,RALAINIRINA N,et al.PI3Kγ is a molecular switch that controls immune suppression[J].Nature,2016,539(7629):437-442. KANEDA M M,MESSER K S,RALAINIRINA N,et al.PI3Kγ is a molecular switch that controls immune suppression[J].Nature,2016,539(7629):437-442.
24、 CHENG N,WATKINS-SCHULZ R,JUNKINS R D,et al.A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer[J].JCI Insight,2018,3(22):e120638. CHENG N,WATKINS-SCHULZ R,JUNKINS R D,et al.A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer[J].JCI Insight,2018,3(22):e120638.
25、 WANG H Y,GE J C,ZHANG F Y,et al.Dendrobium officinale polysaccharide promotes M1 polarization of TAMs to inhibit tumor growth by targeting TLR2[J].Carbohydrate Polymers,2022(292):119683. WANG H Y,GE J C,ZHANG F Y,et al.Dendrobium officinale polysaccharide promotes M1 polarization of TAMs to inhibit tumor growth by targeting TLR2[J].Carbohydrate Polymers,2022(292):119683.
26、 ZHANG Y,CHEN Y,LI J,et al.Development of toll-like receptor agonist-loaded nanoparticles as precision immunotherapy for reprogramming tumor-associated macrophages[J].ACS Appl Mater Interfaces,2021,13(21):24442-24452. ZHANG Y,CHEN Y,LI J,et al.Development of toll-like receptor agonist-loaded nanoparticles as precision immunotherapy for reprogramming tumor-associated macrophages[J].ACS Appl Mater Interfaces,2021,13(21):24442-24452.
27、 WEI B,PAN J,YUAN R,et al.Polarization of tumor-associated macrophages by nanoparticle-loaded escherichia coli combined with immunogenic cell death for cancer immunotherapy[J].Nano Lett,2021,21(10):4231-4240. WEI B,PAN J,YUAN R,et al.Polarization of tumor-associated macrophages by nanoparticle-loaded escherichia coli combined with immunogenic cell death for cancer immunotherapy[J].Nano Lett,2021,21(10):4231-4240.
28、 CHEN B,GAO A,TU B,et al.Metabolic modulation via mTOR pathway and anti-angiogenesis remodels tumor microenvironment using PD-L1-targeting codelivery[J].Biomaterials,2020(255):120187. CHEN B,GAO A,TU B,et al.Metabolic modulation via mTOR pathway and anti-angiogenesis remodels tumor microenvironment using PD-L1-targeting codelivery[J].Biomaterials,2020(255):120187.
29、 YE J,YANG Y,JIN J,et al.Targeted delivery of chlorogenic acid by mannosylated liposomes to effectively promote the polarization of TAMs for the treatment of glioblastoma[J].Bioactive materials,2020,5(3):694-708. YE J,YANG Y,JIN J,et al.Targeted delivery of chlorogenic acid by mannosylated liposomes to effectively promote the polarization of TAMs for the treatment of glioblastoma[J].Bioactive materials,2020,5(3):694-708.
30、 YE J,YANG Y,DONG W,et al.Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages[J].Int J Nanomedicine,2019(14):3203-3220. YE J,YANG Y,DONG W,et al.Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages[J].Int J Nanomedicine,2019(14):3203-3220.
31、 OVAIS M,GUO M,CHEN C.Tailoring nanomaterials for targeting tumor-associated macrophages[J].Adv Mater,2019,31(19):e1808303. OVAIS M,GUO M,CHEN C.Tailoring nanomaterials for targeting tumor-associated macrophages[J].Adv Mater,2019,31(19):e1808303.
32、 GAN J,DOU Y,LI Y,et al.Producing anti-inflammatory macrophages by nanoparticle-triggered clustering of mannose receptors[J].Biomaterials,2018(178):95-108. GAN J,DOU Y,LI Y,et al.Producing anti-inflammatory macrophages by nanoparticle-triggered clustering of mannose receptors[J].Biomaterials,2018(178):95-108.
33、 ZHANG H,ZHANG X,REN Y,et al.An in situ microenvironmental nano-regulator to inhibit the proliferation and metastasis of 4T1 tumor[J].Theranostics,2019,9(12):3580-3594. ZHANG H,ZHANG X,REN Y,et al.An in situ microenvironmental nano-regulator to inhibit the proliferation and metastasis of 4T1 tumor[J].Theranostics,2019,9(12):3580-3594.
34、 CHEN S,QIN F,WANG M,et al.Nanoparticles targeting tumor-associated macrophages:A novel anti-tumor therapy[J].Nano Research,2022,15(3):2177-2195. CHEN S,QIN F,WANG M,et al.Nanoparticles targeting tumor-associated macrophages:A novel anti-tumor therapy[J].Nano Research,2022,15(3):2177-2195.
35、 NG K K,LOVELL J F,ZHENG G.Lipoprotein-inspired nanoparticles for cancer theranostics[J].Acc Chem Res,2011,44(10):1105-1113. NG K K,LOVELL J F,ZHENG G.Lipoprotein-inspired nanoparticles for cancer theranostics[J].Acc Chem Res,2011,44(10):1105-1113.
36、 PANYAM J,LABHASETWAR V.Biodegradable nanoparticles for drug and gene delivery to cells and tissue[J].Adv Drug Deliv Rev,2003,55(3):329-347. PANYAM J,LABHASETWAR V.Biodegradable nanoparticles for drug and gene delivery to cells and tissue[J].Adv Drug Deliv Rev,2003,55(3):329-347.
37、 QIAN Y,QIAO S,DAI Y,et al.Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages[J].ACS Nano,2017,11(9):9536-9549. QIAN Y,QIAO S,DAI Y,et al.Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages[J].ACS Nano,2017,11(9):9536-9549.
38、 SHI J,KANTOFF P W,WOOSTER R,et al.Cancer nanomedicine:progress,challenges and opportunities[J].Nat Rev Cancer,2017,17(1):20-37. SHI J,KANTOFF P W,WOOSTER R,et al.Cancer nanomedicine:progress,challenges and opportunities[J].Nat Rev Cancer,2017,17(1):20-37.
39、 NAJAFI M,HASHEMI GORADEL N,FARHOOD B,et al.Macrophage polarity in cancer:A review[J].J Cell Biochem,2019,120(3):2756-2765. NAJAFI M,HASHEMI GORADEL N,FARHOOD B,et al.Macrophage polarity in cancer:A review[J].J Cell Biochem,2019,120(3):2756-2765.
40、 NGAMBENJAWONG C,GUSTAFSON H H,PUN S H.Progress in tumor-associated macrophage(TAM)-targeted therapeutics[J].Adv Drug Deliv Rev,2017(114):206-221. NGAMBENJAWONG C,GUSTAFSON H H,PUN S H.Progress in tumor-associated macrophage(TAM)-targeted therapeutics[J].Adv Drug Deliv Rev,2017(114):206-221.
41、 MURRAY P J,ALLEN J E,BISWAS S K,et al.Macrophage activation and polarization:nomenclature and experimental guidelines[J].Immunity,2014,41(1):14-20. MURRAY P J,ALLEN J E,BISWAS S K,et al.Macrophage activation and polarization:nomenclature and experimental guidelines[J].Immunity,2014,41(1):14-20.
42、 SYLVESTRE M,CRANE C A,PUN S H.Progress on modulating tumor-associated macrophages with biomaterials[J].Adv Mater,2020,32(13):e1902007. SYLVESTRE M,CRANE C A,PUN S H.Progress on modulating tumor-associated macrophages with biomaterials[J].Adv Mater,2020,32(13):e1902007.
43、 QIAN B Z,POLLARD J W.Macrophage diversity enhances tumor progression and metastasis[J].Cell,2010,141(1):39-51. QIAN B Z,POLLARD J W.Macrophage diversity enhances tumor progression and metastasis[J].Cell,2010,141(1):39-51.
44、 CHEN Q,ZHANG X H,MASSAGUé J.Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs[J].Cancer cell,2011,20(4):538-549. CHEN Q,ZHANG X H,MASSAGUé J.Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs[J].Cancer cell,2011,20(4):538-549.
45、 SU S,LIU Q,CHEN J,et al.A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis[J].Cancer cell,2014,25(5):605-620. SU S,LIU Q,CHEN J,et al.A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis[J].Cancer cell,2014,25(5):605-620.
46、 QIAN B Z,LI J,ZHANG H,et al.CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis[J].Nature,2011,475(7355):222-225. QIAN B Z,LI J,ZHANG H,et al.CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis[J].Nature,2011,475(7355):222-225.
47、 WYNN T A,CHAWLA A,POLLARD J W.Macrophage biology in development,homeostasis and disease[J].Nature,2013,496(7446):445-455. WYNN T A,CHAWLA A,POLLARD J W.Macrophage biology in development,homeostasis and disease[J].Nature,2013,496(7446):445-455.
48、 BASLAN T,HICKS J.Unravelling biology and shifting paradigms in cancer with single-cell sequencing[J].Nat Rev Cancer,2017,17(9):557-569. BASLAN T,HICKS J.Unravelling biology and shifting paradigms in cancer with single-cell sequencing[J].Nat Rev Cancer,2017,17(9):557-569.
49、 PAGET S.The distribution of secondary growths in cancer of the breast[J].Lancet,1889,133(3421):571-573. PAGET S.The distribution of secondary growths in cancer of the breast[J].Lancet,1889,133(3421):571-573.
下一篇
作者登录
作者注册
审稿登录
编辑登录
最新资讯

“精神心理与脑科学：前沿与实践”专题征稿启事

发布于: 2026-05-29

“胶质瘤精准诊疗”专题征稿启事

发布于: 2026-05-29

“人工智能与医学融合”专题征稿启事

发布于: 2025-02-19

征稿 |《广州医药》—“医院管理”专栏征稿

发布于: 2025-01-21
学术活动

会议通知|人工智能赋能学科高质量发展专题讲座

发布于: 2025-02-19

广州市第一人民医院烧伤整形美容与创面修复科举办首期EWMA创面管理与修复培训班

发布于: 2026-05-29

提质增效，创新作为，不断提升麻醉服务能力2024工作总结与2025工作计划

发布于: 2025-02-19

2026年广州市医学会血液学分会学术年会暨再生障碍性贫血研讨会圆满落幕

发布于: 2026-06-01
出版者信息






《广州医药》公众号
目录
友情链接
关注微信公众号
首页   | 关于我们   | 联系我们  粤ICP备17084739号-3
关注微信公众号
粤ICP备17084739号-3